Case Reports

56-year-old woman • worsening pain in left upper arm • influenza vaccination in the arm a few days prior to pain onset • Dx?

Author and Disclosure Information

 

References

Management of SIRVA

Management of SIRVA is similar to that of other shoulder injuries. Treatment may include icing the shoulder, NSAIDs, intra­-articular steroid injections, and physical therapy. If conservative management does not resolve the patient’s pain and improve function, then a consult with an orthopedic surgeon is recommended to determine if surgical intervention is required.

Vaccines should be injected at a 90° angle into the central and thickest portion of the deltoid muscle approximately 2” below the acromion process.

Another case report from Japan reported that a 45-year-old woman developed acute pain following a third injection of ­Cervarix, the prophylactic human papillomavirus-16/18 vaccine. An x-ray was ordered and was normal, but an MRI revealed acute subacromial bursitis. In an attempt to relieve the pain and improve her mobility, multiple cortisone injections were administered and physical therapy was performed. Despite the conservative treatment efforts, she continued to have pain and limited mobility in the shoulder 6 months following the onset of symptoms. As a result, the patient underwent arthroscopic synovectomy and subacromial decompression. One week following the surgery, the patient’s pain improved and at 1 year she had no pain and full range of motion.4

Prevention of SIRVA

By using appropriate techniques when administering intramuscular vaccinations, SIRVA can be prevented. The manufacturer recommended route of administration is based on studies showing maximum safety and immunogenicity, and should therefore be followed by the individual administering the vaccine.5 The Centers for Disease Control and Prevention recommends using a 22- to 25-gauge needle that is long enough to reach into the muscle and may range from ⅝" to 1½" depending on the patient’s weight.6 The vaccine should be injected at a 90° angle into the central and thickest portion of the deltoid muscle, about 2" below the acromion process and above the level of the axilla.5

Our patient’s outcome. The patient’s symptoms resolved within 10 days of receiving a steroid injection into the subacromial space. Although this case was the result of the influenza vaccine, any intramuscularly injected vaccine could lead to SIRVA.

THE TAKEAWAY

Inappropriate administration of routine intramuscularly injected vaccinations can lead to significant patient harm, including pain and disability. It is important for physicians to be aware of SIRVA and to be able to identify the signs and symptoms. Although an MRI of the shoulder is helpful in confirming the diagnosis, it is not necessary if the physician takes a thorough history and performs a comprehensive shoulder exam. Routine x-rays do not provide any beneficial clinical information.

CORRESPONDENCE
Bryan Farford, DO, Department of Family Medicine, Mayo Clinic, Davis Building, 4500 San Pablo Road South #358, Jacksonville, FL 32224; farford.bryan@mayo.edu

Pages

Recommended Reading

Cannabis frequently is used for endometriosis pain
MDedge Family Medicine
Elagolix is effective second-tier treatment for endometriosis-associated dysmenorrhea
MDedge Family Medicine
OA management guidelines forgo treatment hierarchy or order but emphasize severity, patient risk factors
MDedge Family Medicine
Survey: Cancer-related pain, opioid use up since 2018
MDedge Family Medicine
In addiction, abusive partners can wreak havoc
MDedge Family Medicine
Well-tolerated topical capsaicin formulation reduces knee OA pain
MDedge Family Medicine
FDA okays ubrogepant for acute migraine treatment
MDedge Family Medicine
FDA committee rejects oxycodegol, new opioid designed for less abuse
MDedge Family Medicine
FDA advisers set high bar for new opioids
MDedge Family Medicine
Cannabis for sleep: Short-term benefit, long-term disruption?
MDedge Family Medicine